EPS International Co., Ltd. (EPS INTERNATIONAL), a new subsidiary of a public listed company EPS Co., Ltd.(EPS) in Tokyo, Japan, commences its business operations in April 2007. EPS INTERNATIONAL aims to provide a seamless clinical research and development platform through strategizing and synergizing its established research networks, valuable knowledge, know-how, resources and experiences in Asia region.
EPS INTERNATIONAL is fully supported by a team of high caliber, diligent and dedicated clinical professionals having many years of experiences in managing large- and small-scale, global and local clinical trials covering from first-in-man to post marketing surveillance for new chemical entities, biologics and medical devices.